Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP Breakapart Rearrangement Probe

Archives of Pathology and Laboratory Medicine

Volumn 132, Issue 6, 2008, Pages 952-957

  Willmore Payne, Carlynn ^a   Holden, Joseph ^b   Turner, Kristi C ^d   Proia, Alan ^c   Layfield, Lester J ^b  

^a ARUP LABORATORIES   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Department of Pathology ^*  (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; COMPLEMENTARY DNA; DDIT3 PROTEIN, HUMAN; DIAGNOSTIC AGENT; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153;

ARTICLE; CHOP GENE; CHROMOSOME 12; CHROMOSOME 12Q; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE; GENE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; LIPOMA; LIPOSARCOMA; MYOMETRIUM; MYXOSARCOMA; OLIGONUCLEOTIDE PROBE; ANALYTICAL EQUIPMENT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETICS;

CHROMOSOMES, HUMAN, PAIR 12; DNA, COMPLEMENTARY; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOSARCOMA; REAGENT KITS, DIAGNOSTIC; TRANSCRIPTION FACTOR CHOP; TRANSLOCATION, GENETIC;

EID: 45549106084     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kuroda M, Ishida T, Horiuchi H, et al. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. Am J Pathol. 1995;147:1221-1227.
2. Antonescu CR, Elahi A, Humphrey M, et al. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcoma. J Mol Diagn. 2000;2:132-138.
3. Rubin BP, Dal Cin P. The genetics of lipomatous tumors. Semin Diagn Pathol. 2001;18:286-293.
4. Pilotti S, Della Torre G, Lavarino C, et al. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4 containing amplicons at 12q 13-22. J Pathol. 1998;185:188-190.
5. Dei Tos AP, Doglioni C, Piccinin S, et al. Coordinated expression and amplification of the MDM2, CDK4 and HMG1-C genes in atypical lipomatous tumors. J Pathol. 2000;190:521-536.
6. Pilotti S, Della Torre G, Lavarino C, et al. Distinct MDM2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol. 1997;181:14-24.
7. Berner JM, Forus A, Elkahloun A, Meltzer PS, Fodstad O, Myklebest O. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer. 1996;17:254-259.
8. Willeke F, Riddle R, Mechtersheimer G, et al. Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications. Clin Cancer Res. 1998;4:1779-1784.
9. Roberts WM, Douglas EC, Peiper SC, Houghton PJ, Look AT. Amplification of the gli gene in childhood sarcomas. Cancer Res. 1989;49:5407-5413.
10. Forus A, Schmitt JM, Pedetour F, et al. Amplification of 12q 13-14 in human sarcoma: is there a common selective gene or are different mechanisms important in different sets of tumors? Cytogenet Cell Genet. 1995;67:269.
11. Smita SH, Weiss SW, Jankowski SA, Coccia MA, Meltzer PS. SAS amplification in soft tissue sarcomas. Cancer Res. 1992;52:3746-3749.
12. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res. 1993;53:5535-5541.
13. Hostein I, Pelmus M, Aurias A, Pedeutour F, Mathoulin-Pélissier S, Coindre JM. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumorsAvell differentiated liposarcomas. J Pathol. 2004;202:95-102.
14. Miyajima K, Tamiya S, Oda Y, et al. Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma: real time semi-quantitative reverse transcription-polymerase chain reaction. Cancer Letl. 2001;164:177-188.
15. Boltze C, Schneider-Stock R, Jager V. Distinction between lipoma and liposarcoma by MDM2alterations: a case report of simultaneously occurring tumors and review of the literature. Pathol Res Pract. 2001;197:563-568.
16. Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: lipoma. Cancer Genet Cytogenet. 2004;150:93-115.
17. Dal Cin P, Kools P, Sciot R, et al. Cytogenetics and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet. 1993;68:85-90.